According to a TechSci Research report, the global Menopausal Hot Flashes Treatment market is expected to grow at an impressive rate from 2024 to 2028. This growth can be attributed to the increasing number of women worldwide, as well as the rising incidence of menopausal hot flashes symptoms, particularly in North America and Europe, due to lifestyle factors like alcohol consumption, unhealthy eating habits, and smoking. The digitally literate 50-60-year-old women’s growing awareness about menopause-related issues through social media is also expected to drive market growth. Additionally, research and development focusing on reducing hot flashes in women by targeting the brain’s thermostat is expected to contribute to market growth. The market is further expected to benefit from increased investment by government organizations in developing new drugs for menopausal hot flashes treatment.
However, the use of hormonal products in the treatment of hot flashes may have side effects that could slow down the market’s growth during the forecast period. Moreover, the lack of awareness about new drugs for the treatment of menopausal hot flashes in emerging countries could hinder market growth. Additionally, the negative impact of menopausal hot flashes treatment in rural areas among women could further restrict the market’s growth during the forecast period.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on “Global Menopausal Hot Flashes Treatment Market“- https://www.techsciresearch.com/report/menopausal-hot-flashes-treatment-market/14691.html
The global Menopausal Hot Flashes Treatment market can be categorized based on type, treatment type, distribution channel, and region. The treatment type segment is further divided into hormonal treatment, non-hormonal treatment, and alternative treatment. Hormonal treatment dominated the market in 2022 and is expected to maintain its dominance throughout the forecast period. This can be attributed to the growing incidence of menopausal hot flashes due to factors such as alcohol consumption, spicy foods, and caffeine. The commercialization of new drugs during the forecast period, along with technological advancements in the production of new medications by major innovators, is also expected to contribute to the growth of this segment.
The distribution channel segment is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment is expected to dominate during the forecast period due to increasing demand by consumers such as pharmaceutical stores, hospitals, drug stores, and clinics for better supply and discounts for patients. Additionally, the increasing female population, along with growth in the number of retail outlets, is expected to boost the demand for women’s health products in emerging countries like India and China, further contributing to market growth.
Major companies operating in the global Menopausal Hot Flashes Treatment market are:
- AbbVie Inc.
- Allergan PLC.
- Bayer Ag.
- Cipla, Inc.
- Eli Lilly and Company
- Emcure Pharmaceuticals Ltd.
- GSK PLC.
- Glenmark Pharmaceuticals Ltd.
- Hisamitsu Pharmaceutical Co. Inc.
- Merck & Co. Inc.
- Novartis Ag.
- Novo Nordisk AS.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- TherapeuticsMD, Inc.
For instance, in November 2021, Theramex launched a product Femarelle, an OTC product for treating menopausal symptoms. The product was originally developed by Se-cure Pharmaceuticals Ltd. and was available in different countries by 2022.
In December 2020, biopharmaceutical company Sojournix announced that it had resumed its Phase 2 trial of SJX-653, a novel, potent, and selective neurokinin 3 (NK3) antagonist for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause, which commonly causes hot flashes.
Customers can also request for 10% free customization on this report.
“North America is expected to dominate the Global Menopausal Hot Flashes Treatment market owing to the growing consumption of antibiotics due to increasing the number of women population with menopausal symptoms across the region. Similarly, due to the growing baby boomer population, and growing healthcare expenditure, the large number of prescriptions of hormonal as well as non-hormonal treatment products is further expected to boost the growth of the market during the forecast period. Furthermore, growing public awareness about menopausal hot flashes treatment, increasing medical tourism, and rising government initiatives for women’s health in the region are further contributing to the demand for menopausal hot flashes treatment. Besides, the growing number of new companies in the market and technological advancements in the development of new drugs for the treatment of menopausal hot flashes is further expected to create lucrative opportunities for market growth,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“Menopausal Hot Flashes Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Type (Oral Liquid v/s Pill), By Treatment Type (Hormonal Treatment, Non-Hormonal Treatment, Alternative Treatment), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, and Competition”, has evaluated the future growth potential of global Menopausal Hot Flashes Treatment market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the Global Menopausal Hot Flashes Treatment market.
Download Free Sample Report- https://www.techsciresearch.com/sample-report.aspx?cid=14691
Related Reports:
Europe pharmacovigilance market
Europe humanized mice model market
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com